Senior Director, Asset Team Leader in Oncology (Non-MD)

La Jolla, California
September 25 2021
Life Sciences, Oncology
Position Type
Full Time
Organization Type

This position is accountable for developing and driving the early development strategy of assets in ORD (Oncology Research & Development), a division of WRDM, in alignment with the overall ORD and Pfizer portfolio strategy. The early development asset team leader (ATL) leads the asset team (AT) and is accountable for the seamless execution of all project deliverables from candidate selection and IND enabling deliverables leading to First in Patient and up to the time an asset may transition to the appropriate late phase development organization. The ATL will be responsible for approval of program and/or project plans, and endorsement and integration of strategies. The early development ATL applies scientific knowledge and clinical and drug development experience to ensure the research and development strategy of the AT can address unmet medical needs and commercial strategies.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact

  • Oversees clinical portfolio development from pre-FIH through transition to late development.
  • Leads cross-functional Asset Team(s) composed of the following standing member line functions: Clinical lead, Clinical Operations program lead, Nonclinical project lead, Development director, Translational lead, Commercial lead, Pharmaceutical Sciences team lead, and Project Management.
  • Will also include other functional line leads (Regulatory, Clinical Pharmacology, DMPK, PK/PD Modeling, Biostatistics, Legal, etc.) in asset development planning and execution, as needed
  • Endorses and integrates line function strategies.
  • Accountable for developing projects that are cost-effective and looks to de-risk the candidate and investments as early as practical (clinical portfolio level).
  • Accountable for ensuring that the projects are managed appropriately per budget.
  • Accountable for ensuring that the necessary resources are available to the projects to support their success.
  • Accountable for communicating across lines and functions to facilitate timely and effective decision-making. Prepares teams for project reviews and governance milestone decisions, ensuring high quality and delivering objective and comprehensive assessments of team strategy and project status.
  • Accountable for the quality of asset deliverables to external authorities.
  • Promotes a culture of innovation and inclusivity within Asset Teams in order to bring forward creative development plans that maximize the potential of the asset.

ATLs may be selected from diverse scientific backgrounds, but they must exhibit significant learning agility, build deep knowledge of disease biology, and are responsible for championing innovative scientific strategies to deliver differentiated medicines that treat cancer indications.

  • PhD, PharmD or advanced scientific degreewith post-graduate clinical training/development and experience in clinical medicine or drug development
  • Minimum of 10 years (15 years preferred) of relevant post graduate experience in the pharmaceutical, academic and/or medical research environments having successfully executed a major component of a development program(s), with a substantial portion of that experience in Oncology / Immuno-oncology
  • Strong understanding of the elements of drug development programs and experience in their design and execution.
  • Filing and defense of INDs, CTAs and full dossiers.
  • Successful demonstration of experience leading matrix drug discovery teams
  • Exceptional interpersonal communications and negotiation skills are essential dimension of this role

Other Job Details:
  • Eligible for Relocation Package
  • Eligible for Employee Referral Bonus
  • #LI-PFE

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.


Similar jobs

Similar jobs